๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› TNBC, Triple Negative Breast Cancer
Clinical trial register · China

TNBC, Triple Negative Breast Cancer Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Shanghai 10 Hangzhou 2 Nanjing 2 Wuhan 2 Hefei 2
Narrow the registerReset
Recruitment status
Phase
Site location
Shanghai10 Hangzhou2 Nanjing2 Wuhan2 Hefei2
All 14 locations
Target enrolment
to

TNBC, Triple Negative Breast Cancer trials in China

19 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Real-world Patient-reported Outcome of Sacituzumab Govitecan in Chinese Metastatic Breast Cancer
NCT07551050TNBC - Triple-Negative Breast Cancer
Fudan University
Observational
300
Shanghai
2026-05-15
Not yet open
Comparison of Chemotherapy and Immunotherapy in Neoadjuvant Therapy for TNBC
NCT07523789TNBC, Triple Negative Breast Cancer
The First Affiliated Hospital with Nanjing Medical University
Observational
201
Nanjing
2026-05-01
Recruiting
Study of Radiotherapy Combined With Cisplatin/Carboplatin, Adebrelimab and Bevacizumab in the Treatment of TNBC-BM.
NCT07638852TNBC, Triple Negative Breast Cancer, Brain Metastasases
Fudan University
Phase 2
58
Shanghai
2026-02-02
Recruiting
A Single-Arm Phase โ…ก Study of Fluzoparib Maintenance in Platinum-sensitive Advanced Triple-Negative Breast Cance
NCT07321015Platinum-sensitive, TNBC, Triple Negative Breast Cancer, BRCA1/2 Mutation or Not
Tianjin Medical University Cancer Institute and Hospital
Phase 2
72
Tianjin
2026-01-20
Recruiting
Neoadjuvant Toripalimab Plus SBRT for Chemo-Resistant Triple-Negative Breast Cancer
NCT07457359TNBC, Triple Negative Breast Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
18
Hangzhou
2026-01-04
Recruiting
Neoadjuvant Chemotherapy Combined With Sintilimab and Bevacizumab for TNBC (NEOTORCH-BREAST07)
NCT07351487TNBC - Triple-Negative Breast Cancer
First Affiliated Hospital of Zhejiang University
Phase 2
37
Hefei, Shanghai
2025-09-25
Recruiting
Trop-2 Targeted PET Probes in Advanced TNBC
NCT07046455TNBC - Triple-Negative Breast Cancer
Peking University Cancer Hospital & Institute
Not applicable
20
Beijing
2025-03-01
Not yet open
Real-world Patient-reported Outcome of Sacituzumab Govitecan in Chinese Metastatic Triple-negative Breast Cancer
NCT06798506TNBC - Triple-Negative Breast Cancer
Fudan University
Observational
300
Shanghai
2025-02-15
Recruiting
SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC
NCT06627712TNBC - Triple-Negative Breast Cancer
West China Hospital
Phase 3
318
Sichuan
2024-11-01
Recruiting
QL1706 Plus Chemotherapy +/- Bevacizumab in 1L Treatment of R/mTNBC
NCT06786026TNBC, Triple Negative Breast Cancer
Fudan University
Phase 2
60
Shanghai
2024-10-09
Recruiting
Neoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02)
NCT06682195TNBC, Triple Negative Breast Cancer
First Affiliated Hospital of Zhejiang University
Phase 2
35
Nanchang, Hangzhou, Harbin, Hefei, Jinhua, Nantong, Shanghai, Shanxi
2024-10-09
Recruiting
LM-108 in Combination With PD-1 Based Treatment for Patients With Recurrent or Metastatic Triple - Negative Breast Cancer
NCT06387628TNBC - Triple-Negative Breast Cancer
Fudan University
Phase 2
74
Shanghai
2024-07-10
Not yet open
QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Early High-Risk TNBC Breast Cancer
NCT06404736Early Breast Cancer, Neoadjuvant Therapy, TNBC, Triple Negative Breast Cancer
Fudan University
Phase 2
73
Shanghai
2024-05-07
Recruiting
Estrogen Receptor (ER) PET/CT Imaging in Breast Cancer
NCT05541367Breast Cancer, TNBC - Triple-Negative Breast Cancer, Estrogen-receptor-negative Breast Cancer
Tongji Hospital
Observational
80
Wuhan
2021-12-31
Rows per page Showing 1–19 of 19
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/condition/tnbc-triple-negative-breast-cancer

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 19 of those studies listing the condition TNBC, Triple Negative Breast Cancer.

How many TNBC, Triple Negative Breast Cancer trials are recruiting in China?

16 of the 19 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 3 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (TNBC, Triple Negative Breast Cancer), 19 studies
PhaseStudiesRecruitingShare
Phase 210952.6%
Observational4221.1%
Phase 33315.8%
Not applicable115.3%
Phase 1115.3%

Most active sponsors

Lead sponsors with the most studies (TNBC, Triple Negative Breast Cancer)
Lead sponsorStudiesRecruiting
Fudan University86
First Affiliated Hospital of Zhejiang University22
Huihua Xiong11
Jiangsu Cancer Institute & Hospital11
Peking University Cancer Hospital & Institute11
Second Affiliated Hospital, Zhejiang University, School of Medicine11
The First Affiliated Hospital with Nanjing Medical University10
Tianjin Medical University Cancer Institute and Hospital11
Tongji Hospital11
West China Hospital11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.